Genor Biopharma Co., Ltd.
Building 3, 1690 Zhangheng Road
3 articles with Genor Biopharma Co., Ltd.
Collaboration to evaluate combination of APG-115, Ascentage's MDM2-p53 inhibitor and genolimzumab, Genor's anti-PD-1 monoclonal antibody in solid tumors and blood cancers
CBT Pharmaceuticals Receives First Australian Ethics Approval to Initiate APOLLO-1 Phase 1/2 Clinical Trial for Hepatocellular and Renal Cell Carcinoma
CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company committed to becoming a leader in the discovery and development of oncology combination therapies, today announced the receipt of ethics approval from the Bellberry Human Research Ethics Committee (HREC) in Australia for its planned APOLLO-1 clinical trial.
Genor Biopharma, Walvax’s, Partners With Mabspace Biosciences To Discover And Develop Novel Antibody Therapeutics